BRCC3 antibody (AA 266-316)
Quick Overview for BRCC3 antibody (AA 266-316) (ABIN1977072)
Target
See all BRCC3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 266-316
-
Specificity
- Region between residue 266 and 316 of human BRCA1/BRCA2-containing complex subunit 36 using the numbering given in entry NP_077308.1 (GeneID 79184).
-
Purification
- Immunoaffinity purified
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: IF (1:250 - 1:2000), IHC, IHC-P (1:500 - 1:2000), IP (2 - 5 μg/mg lysate), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Ovarian Carcinoma, Prostate Carcinoma. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-citrate/phosphate buffer, pH 7-8, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2-8°C for up to 1 year.
-
Expiry Date
- 12 months
-
-
- BRCC3 (BRCA1/BRCA2-Containing Complex, Subunit 3 (BRCC3))
-
Alternative Name
- BRCC3 / BRCC36
-
Background
-
Name/Gene ID: BRCC3
Synonyms: BRCC3, C6.1A, BRCC36, BRISC complex subunit BRCC36, BRCA1-A complex subunit BRCC36, CXorf53, RP11-143H17.2 -
Gene ID
- 79184
-
Pathways
- Positive Regulation of Response to DNA Damage Stimulus
Target
-